Wenming Chen
Chief Physician
Department of Hematology
Beijing Chaoyang Hospital

EXPERTISE: The main research direction is the basic and clinical aspects of multiple myeloma. Research on the early diagnosis and treatment of multiple myeloma has been carried out, mainly including: chemotherapy, hematopoietic stem cell transplantation, immunotherapy, anti-angiogenesis treatment and bone disease treatment, etc., so that the overall survival time of patients has increased from 3-4 internationally. The period is extended to 4-5 years, and some patients survive for a long time..

KEYWORDS: multiple myeloma

More Doctors

Xu Ying | Chief Physician, Professor at Peking Union Medical College Hospital

Ying Xu
Chief Physician, Professor
Special Needs Hematology Department
Peking Union Medical College Hospital
Zhang Lina | Deputy Chief Physician at China Academy of Chinese Medical Sciences Guang'anmen Hospital

Lina Zhang
Deputy Chief Physician
Department of Hematology
China Academy of Chinese Medical Sciences Guang'anmen Hospital
Dong Qian | Chief Physician at China Academy of Chinese Medical Sciences Guang'anmen Hospital

Qian Dong
Chief Physician
Department of Oncology
China Academy of Chinese Medical Sciences Guang'anmen Hospital
Jiang Qian | Chief Physician, Associate Professor at Peking University People's Hospital

Qian Jiang
Chief Physician, Associate Professor
Department of Hematology
Peking University People's Hospital
Li Rongsheng | Chief Physician, Doctoral Supervisor at Peking Union Medical College Hospital

Rongsheng Li
Chief Physician, Doctoral Supervisor
Department of Hematology
Peking Union Medical College Hospital